021-51111890
购物车（）
sales@molnova.cn
Biotin-PEG4-azide
CAS No. 1309649-57-7
Biotin-PEG4-azide ( —— )
产品货号. M26908 CAS No. 1309649-57-7
Biotin-PEG4-azide is a biotin-labeled, PEG-based PROTAC linker that can be used in the synthesis of PROTACs.
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 25MG | ￥535 | 有现货 |
|
| 50MG | ￥786 | 有现货 |
|
| 100MG | ￥1345 | 有现货 |
|
| 200MG | 获取报价 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称Biotin-PEG4-azide
-
注意事项本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断
-
产品简述Biotin-PEG4-azide is a biotin-labeled, PEG-based PROTAC linker that can be used in the synthesis of PROTACs.
-
产品描述Biotin-PEG4-azide is a biotin-labeled, PEG-based PROTAC linker that can be used in the synthesis of PROTACs.(In Vitro):PROTACs contain two different ligands connected by a linker; one is a ligand for an E3 ubiquitin ligase and the other is for the target protein. PROTACs exploit the intracellular ubiquitin-proteasome system to selectively degrade target proteins.
-
同义词——
-
通路Others
-
靶点Other Targets
-
受体——
-
研究领域——
-
适应症——
化学信息
-
CAS Number1309649-57-7
-
分子量488.6
-
分子式C20H36N6O6S
-
纯度>98% (HPLC)
-
溶解度——
-
SMILES[H][C@]12CS[C@@H](CCCCC(=O)NCCOCCOCCOCCOCCN=[N+]=[N-])[C@@]1([H])NC(=O)N2
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Demczuk A, Kowalewska-Piontas J, Bednarski W. The effect of some conditions on the secretion of extracellular beta-galactosidase synthesised by Kluyveromyces fragilis 28. Commun Agric Appl Biol Sci. 2003;68(2 Pt B):469-72.
产品手册
关联产品
-
THCA-A (CRM)
THCA-A (CRM) is a certified reference material categorized as a phytocannabinoid.1 THCA-A is a common component of hashish but is non-psychoactive until heated via smoking, which converts it to Δ9-THC.
-
Glycyrrhizinic acid ...
Glycyrrhizinic acid potassium salt?can reduce ventricular arrhythmias caused by veratrol.
-
MID-1
MID-1 is an inhibitor of MG53-IRS-1 (Mitsugumin 53-Insulin Receptor Substrate-1) interaction.?It disrupts molecular association of MG53 with IRS-1 and abolishes MG53-induced IRS-1 ubiquitination and degradation in skeletal muscle, leading to elevated IRS-1 expression level and increased insulin signaling and glucose uptake.
